US President Donald Trump's decision to impose punitive tariffs of 145% for pharmaceutical imports from China,1 effective since April 10, 2025, will pose substantial challenges towards global health ...

Advancing diabetes therapy requires an integrative approach that uses emerging technologies. This research topic focuses on the synergy between ...

Blake Powers, CEO, Medigi, discusses how face-to-face collaboration and streamlined commercialization strategies are helping life sciences companies deliver therapies more efficiently to patients.

Azitra Inc., a Branford-based biopharmaceutical firm, said Thursday it has entered into a share purchase agreement with New ...